(VIANEWS) – ING GROEP N.V. (INGA.AS), SPAREBANK 1 SMN (MING.OL), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ING GROEP N.V. (INGA.AS)
24.2% sales growth and 25.17% return on equity
ING Groep N.V., a financial institution, provides various banking products and services in the Netherlands, Belgium, Rest of Europe, North America, Latin America, Asia, and Australia. It operates in six segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The company accepts various deposits, such as current and savings accounts. It also offers business lending products; consumer lending products, such as residential mortgage loans, term loans, and other consumer lending loans; and secured and unsecured lending services. in addition, the company provides debt capital market, working capital solutions, export finance, daily banking, treasury and risk, and corporate finance solutions; and specialized lending, debt and equity market solutions, payments and cash management, and trade and treasury services, as well as savings, investment, insurance, mortgage, and digital banking services; and SME loans. It serves individual customers, corporate clients, and financial institutions. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ING GROEP N.V. has a trailing twelve months EPS of €1.34.
PE Ratio
ING GROEP N.V. has a trailing twelve months price to earnings ratio of 9.38. Meaning, the purchaser of the share is investing €9.38 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.17%.
Moving Average
ING GROEP N.V.’s value is way higher than its 50-day moving average of €11.38 and way above its 200-day moving average of €11.14.
Volume
Today’s last reported volume for ING GROEP N.V. is 2238590 which is 80.33% below its average volume of 11382300.
More news about ING GROEP N.V..
2. SPAREBANK 1 SMN (MING.OL)
22.7% sales growth and 12.31% return on equity
SpareBank 1 SMN, together with its subsidiaries, provides various banking, accounting, and real estate products and services to private individuals and companies in Norway and internationally. The company offers mortgage, car, boat, other vehicles, and consumer loans; refinancing; and current, savings, billing, business, group, tax deduction, currency, and deposit accounts. It also provides BSU house savings for young people; fixed interest deposits; stocks and investments; cash services; and payments. In addition, the company offers vehicle, housing and travel, person, animal, and valuables insurance services; property buying and selling advisory services; and mobile and online banking, and various cards. Further, it offers loans and financing, including bank guarantees, business and construction loans, operating credit for agriculture, factoring, guarantees, leasing, and overdrafts; various pension products; and business and personal insurance products. Additionally, the company provides document collection, letter of credit, future business, and currency option services; and services, including accounting and payroll, HR, taxes and duties, and transfer of ownership, as well as IT solutions. It offers real estate agency, advisory, and external and equity financing services. SpareBank 1 SMN was founded in 1823 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, SPAREBANK 1 SMN has a trailing twelve months EPS of kr11.67.
PE Ratio
SPAREBANK 1 SMN has a trailing twelve months price to earnings ratio of 12.12. Meaning, the purchaser of the share is investing kr12.12 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.31%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 37.2% and 38.1%, respectively.
Moving Average
SPAREBANK 1 SMN’s value is higher than its 50-day moving average of kr135.18 and way higher than its 200-day moving average of kr125.13.
Volume
Today’s last reported volume for SPAREBANK 1 SMN is 13241 which is 90.9% below its average volume of 145613.
More news about SPAREBANK 1 SMN.
3. NAVAMEDIC (NAVA.OL)
21.8% sales growth and 22.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.75.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 22.46. Meaning, the purchaser of the share is investing kr22.46 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 93.3%, now sitting on 440.93M for the twelve trailing months.
Moving Average
NAVAMEDIC’s value is higher than its 50-day moving average of kr38.10 and higher than its 200-day moving average of kr35.78.
Sales Growth
NAVAMEDIC’s sales growth is 10.5% for the present quarter and 21.8% for the next.
Volume
Today’s last reported volume for NAVAMEDIC is 550 which is 98.03% below its average volume of 27941.
More news about NAVAMEDIC.
4. KITRON (KIT.OL)
19.8% sales growth and 24.07% return on equity
Kitron ASA operates as an electronics manufacturing services company in Norway, Sweden, rest of Europe, the United States, and internationally. It manufactures electronics that are embedded in the customers' products; and box-built electronic products. The company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high level assembly lines, and environmental durability testing. Its services also comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance; and logistics and distribution services. The company was incorporated in 1996 and is headquartered in Billingstad, Norway.
Earnings Per Share
As for profitability, KITRON has a trailing twelve months EPS of kr2.23.
PE Ratio
KITRON has a trailing twelve months price to earnings ratio of 19.55. Meaning, the purchaser of the share is investing kr19.55 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.07%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 32.4%, now sitting on 617.39M for the twelve trailing months.
Yearly Top and Bottom Value
KITRON’s stock is valued at kr43.60 at 12:20 EST, below its 52-week high of kr47.20 and way higher than its 52-week low of kr17.38.
Sales Growth
KITRON’s sales growth is 24.7% for the ongoing quarter and 19.8% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 2, 2023, the estimated forward annual dividend rate is 0.5 and the estimated forward annual dividend yield is 1.22%.
More news about KITRON.
5. SANDNES SPAREBANK (SADG.OL)
17% sales growth and 8.32% return on equity
Sandnes Sparebank, an independent savings bank, provides a range of banking and investment products to retail and corporate customers in Norway. It operates through three segments: Retail Market, Corporate Market, and Real Estate. The company offers fixed rate deposits, deposit accounts, BSU, and tax withholding and other accounts; child, death, income, critical illness, disability, car, home, cabin, contents, UNG, and other insurance products; and pension solutions. It also provides bank guarantee, overdrafts, leasing, construction and business loans, factoring and invoice sales; fixed interest, mortgage, car, and other vehicle loans, as well as small loans and refinancing, and green loans; bank and credit cards; various loans and guarantees; and mobile and internet banking services. In addition, the company offers real estate brokerage and general investment advisory services. Sandnes Sparebank was founded in 1875 and is headquartered in Sandnes, Norway.
Earnings Per Share
As for profitability, SANDNES SPAREBANK has a trailing twelve months EPS of kr8.09.
PE Ratio
SANDNES SPAREBANK has a trailing twelve months price to earnings ratio of 10.58. Meaning, the purchaser of the share is investing kr10.58 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.32%.
Volume
Today’s last reported volume for SANDNES SPAREBANK is 632 which is 90.97% below its average volume of 7006.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 29, 2023, the estimated forward annual dividend rate is 6.05 and the estimated forward annual dividend yield is 7.15%.
Yearly Top and Bottom Value
SANDNES SPAREBANK’s stock is valued at kr85.60 at 12:20 EST, way below its 52-week high of kr101.00 and above its 52-week low of kr81.00.
More news about SANDNES SPAREBANK.
6. MEDISTIM (MEDI.OL)
16.7% sales growth and 31.89% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.35.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 43.94. Meaning, the purchaser of the share is investing kr43.94 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.89%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 17.7% and positive 11.1% for the next.
More news about MEDISTIM.
7. TIPIAK (TIPI.PA)
13.7% sales growth and 6.82% return on equity
Tipiak Société Anonyme, a food company, manufactures prepared food products, frozen ready-meals, pastry products, groceries, and crusty bread products. The company offers groceries, such as breadcrumbs, cereals, couscous, croutons, Japanese pearls, potato starch, quinoa, and tapioca; frozen products, including savory products, appetizers, and side dishes with grains; and frozen sweet products comprising macarons, mini eclairs, and petits fours. It sells its products in France, England, and the United States. The company was founded in 1830 and is based in Saint-Aignan-Grandlieu, France.
Earnings Per Share
As for profitability, TIPIAK has a trailing twelve months EPS of €3.7.
PE Ratio
TIPIAK has a trailing twelve months price to earnings ratio of 16.35. Meaning, the purchaser of the share is investing €16.35 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.82%.
Sales Growth
TIPIAK’s sales growth is 13.7% for the present quarter and 13.7% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jul 4, 2023, the estimated forward annual dividend rate is 1.65 and the estimated forward annual dividend yield is 2.8%.
Moving Average
TIPIAK’s worth is higher than its 50-day moving average of €59.56 and above its 200-day moving average of €58.28.
More news about TIPIAK.
8. PARETO BANK (PARB.OL)
11.2% sales growth and 14.03% return on equity
Pareto Bank ASA offers various banking products and services in Norway. The company accepts corporate deposits. It also offers corporate financing; receivables financing; residential and commercial financing for land and property; ship financing, including corporate and project financing; and other private or housing loans. The company was incorporated in 2007 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, PARETO BANK has a trailing twelve months EPS of kr7.89.
PE Ratio
PARETO BANK has a trailing twelve months price to earnings ratio of 6.26. Meaning, the purchaser of the share is investing kr6.26 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.03%.
Moving Average
PARETO BANK’s value is under its 50-day moving average of kr51.01 and below its 200-day moving average of kr50.29.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 31, 2023, the estimated forward annual dividend rate is 3.86 and the estimated forward annual dividend yield is 7.7%.
Sales Growth
PARETO BANK’s sales growth for the next quarter is 11.2%.
More news about PARETO BANK.
